|
|
|
|
New Patent Awarded for Terso RFID Enclosure Technology
New Patent Awarded for Terso Solutions RFID Enclosure Technology Smart enclosure units provide automated item-level inventory management Madison, Wis., March 18, 2010The U.S.Patent and Trademark Office awarded a patent (US 7,661,591 B2) for...
|
|
|
Patent Portfolios Focus on Quality and Innovation Earns High Marks
Chief Patent Counsel Each year the Institute of Electrical and Electronics Engineers (IEEE) rates the quality of companies patent portfolios, and this year again, Microsofts portfolio is rated the strongest in the software industry.Its the third...
|
|
|
Benitec Limited (ASX:BLT) 'Graham' Patent Granted In Japan
- (ABN Newswire) - Benitec Limited (ASX:BLT) (PINK:BNIKF) today announced that a patent 'Control of Gene Expression', part of the Graham patent family of RNA interference (RNAi) patents was granted in Japan.The 'Control of Gene Expression ...
|
|
|
The Medicines Company Provides Update on PTO Litigation
The Medicines Company (NASDAQ: MDCO) today provided an update on actions by the U.S.Patent and Trademark Office (the 'PTO') related to the Company's application pursuant to the Hatch-Waxman Act to extend the term of United States Patent No. 5...
|
|
|
The Medicines Company Provides Update on PTO Litigation
Companies mentioned in this article: The Medicines Company PARSIPPANY, NJ -- (Marketwire) -- 03/19/10 -- The Medicines Company (NASDAQ: MDCO) today provided an update on actions by the U.S.Patent and Trademark Office (the "PTO") related to the Company...
|
|
|
U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter
SOUTH SAN FRANCISCO, Calif.'We view the reissue of the composition of matter patent for picoplatin as a highly successful outcome. Picoplatin's patent estate plays a key role in our ongoing evaluation of strategic opportunities, including...
|
|
|
MorphoSys AG (DE) - MorphoSys Granted Further Patent on its Core Antibody Technology in Japan
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that the Japanese Patent Office has granted a new patent providing extended protection for the Company's core technology HuCAL.The new patent (JP 4436457) covers the...
|
|
|
Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181a Function in Immune Cells
Patent News Breaking News News source: Business Wire Regulus Therapeutics Inc.announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of...
|
|
|
Judge gives Medicines Co. another chance
WillThe Medicines Companyfinally undo its patent-filing mishap?Apparently, a federal judge has taken pity on the company, which filed for its Hatch-Waxman patent extension on Angiomax one day too late? The judge has ordered the U.S. Patent...
|
|
|
ImmunoCellular Therapeutics Receives Allowance of a New Patent on its Antibodies Targeting Pancreatic Cancer
Therapeutics Breaking News News source: Business Wire ImmunoCellular Therapeutics, Ltd.(OTCBB: IMUC), a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of...
|
|
|
A Company Races to Keep a Drug Patent
It has been called a case of being a day late and a billion dollars short potentially one of the costliest blunders in drug industry history.But a court decision this week might be a reprieve for the company involved. Back in 2001, the Medicines Company...
|
|
|
Cordis Corporation - Strategic Analysis Review - new market report published
Cordis Corporation - Strategic Analysis Review Summary The Cordis Corporation - Strategic Analysis Review is an in-depth business and strategic analysis of Cordis Corporation.The report provides a comprehensive insight into the company, including business...
|
|
|
USPTO reissues composition of matter patent for Poniard Pharmaceuticals' picoplatin
Poniard Pharmaceuticals, Inc.(Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that the U.S. Patent & Trademark Office (USPTO) has granted and will reissue the composition of matter patent...
|
|
|
Providence receives U.S. patent for CPMMS
Providence today announces the receipt of a United States Patent for the Comprehensive Particulate Matter Measurement System (CPMMS) and the Methodology for its Use.Yousheng Zeng, PhD, PE, a principal of Providence, is the inventor of this system.
|
|
|
U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter
Companies mentioned in this article: Poniard Pharmaceuticals, Inc.SOUTH SAN FRANCISCO, Calif., March 18 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today...
|
|
|
Apple Files Patent For Hot Potato Clone (AAPL)
Apple filed a patent application for a mobile social networking service called iGroups that sounds an awful lot like Hot Potato , Patently Apple reports.Like Hot Potato, iGroups helps its users "stay in communication with each other as a group to...
|
|
|
Mannatech Vigorously Defends Ambrotose Product Patents With Latest Legal Action Against Multiple Companies
Mannatech, Incorporated (NASDAQ: MTEX), a global pioneer in the development of high-quality health, weight and fitness and skin care solutions based on nutritional science, announced it has filed a complaint against seven independent companies for infringement...
|
|
|
Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181a Function in Immune Cells
CARLSBAD, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc.announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to...
|
|
|
Pfizer drops Viagra infringement case against Lilly
Pfizer Inc agreed to drop an eight-year-old patent infringement lawsuit against Eli Lilly & Co over Viagra after a US government agency rejected part of the male impotence drug's patent.The notice of agreement was filed Monday in Delaware's...
|
|
|
Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181a Function in Immune Cells
CARLSBAD, Calif.-- (BUSINESS WIRE) -- Regulus Therapeutics Inc.announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to...
|
|
|
Seeking Patent Reform in Europe
The European Generic Medicines Association (EGA) is calling for an urgent reform of the European patent system; in particular, the agency stresses that the quality of patent examinations and applications should be improved, and that examination and...
|
|
|
Lady Gaga, DNA and patents
(Fortune) -- When radio was invented in the late nineteenth century by the likes of Marconi, Edison, and Tesla, government and industry faced a conundrum.Who would own the limited band of electromagnetic frequencies that made this new invention possible?
|
|
|
Authernative Granted US and Japanese Patents for User Authentication
Companies mentioned in this article: Authernative, Inc.REDWOOD CITY, Calif., March 17 /PRNewswire/ -- Authernative, Inc., a leading developer of innovative user authentication and identity management technologies, announced today that it recently has been...
|
|
|
SHIRE PLC - Shire Receives INTUNIV Paragraph IV Notice Letter
Shire Receives INTUNIV Paragraph IV Notice Letter from Teva Pharmaceuticals Dublin, Ireland - 16 March 2010 - Shire plc (LSE: SHP, NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc.('Teva')...
|
|
|
Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals
/PRNewswire-FirstCall/ Shire plc (LSE: SHP, NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc.('Teva') advising of the filing of an Abbreviated New Drug Application ('ANDA') for a generic version...
|
